Search

everythinglearnresearchcommunity

for

Search:↓

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Nano-liposome-bound EGF can delay hair growth in rats.

EGF and TGF-α help maintain hair cell cultures, but TGF-β1 stops their growth.

Epidermal growth factor (EGF) boosts the growth of hair follicle cells.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

cgVEGF164 boosts hair follicle growth in mice.

The assay quickly identifies substances that increase or decrease blood vessel growth.

Thyroid hormone and epidermal growth factor affect hair angle, tooth eruption, and ear development in rats.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Epidermal cell extracts improve skin healing and reduce scarring.

Reducing gefitinib dosage improved hair loss, but scarring remained.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.

Targeting EGFR may help reduce hair loss from chemotherapy.

Egfl6 is not needed for zebrafish face development.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

VEGF gel increases hair growth but may have potential toxicity.

Genetic testing for EGFR mutations is crucial in similar cases.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.